PIGA, Isabella
 Distribuzione geografica
Continente #
EU - Europa 17.944
NA - Nord America 142
AS - Asia 76
SA - Sud America 6
OC - Oceania 2
AF - Africa 1
Totale 18.171
Nazione #
IT - Italia 17.895
US - Stati Uniti d'America 142
SG - Singapore 33
CN - Cina 19
DE - Germania 11
HK - Hong Kong 10
FR - Francia 8
BR - Brasile 6
CH - Svizzera 5
GB - Regno Unito 5
NL - Olanda 5
AT - Austria 4
FI - Finlandia 4
IN - India 4
JP - Giappone 4
TW - Taiwan 4
BE - Belgio 3
AU - Australia 2
KR - Corea 2
SE - Svezia 2
CI - Costa d'Avorio 1
ES - Italia 1
HR - Croazia 1
Totale 18.171
Città #
Cagliari 16.641
Uta 1.218
Boardman 105
Singapore 27
Ashburn 10
Hong Kong 10
Milan 9
São Paulo 6
Hefei 4
Kempten (Allgaeu) 4
Los Angeles 4
Taipei 4
Vienna 4
Brookline 3
Cheyenne 3
Grez-Doiceau 3
Helsinki 3
Höri 3
San Donato Milanese 3
Chennai 2
Delhi 2
Illkirch-Graffenstaden 2
Jinan 2
Kadoma 2
Lille 2
London 2
Monza 2
Paris 2
Reading 2
Rockville 2
Salt Lake City 2
Shanghai 2
Sydney 2
Uppsala 2
Xi'an 2
Yixing 2
Zurich 2
Abidjan 1
Bad Bellingen 1
Catania 1
Chapel Hill 1
Chicago 1
Córdoba 1
Forest City 1
Frankfurt am Main 1
Friedberg 1
Guidizzolo 1
Gwanak-gu 1
Halethorpe 1
Krefeld 1
Lappeenranta 1
Leiden 1
Munich 1
Nuremberg 1
Rozzano 1
San Diego 1
San Jose 1
Santa Clara 1
Seoul 1
Southwark 1
Springfield 1
St Louis 1
Taranto 1
Xiamen 1
Zagreb 1
Totale 18.128
Nome #
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 1.150
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 1.042
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 1.024
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 986
Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: a proteomic study 961
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 818
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 734
In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression 688
Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection 662
ADVANCES IN CLINICAL PROTEOMICS FOR ANALYSIS OF THYROID FINE NEEDLE ASPIRATION BIOPSIES: EVALUATING PROTEOMIC STABILITY IN PRESERVATIVE SOLUTIONS 645
A novel Spatial Multi-omics mass spectrometry imaging workflow to assist clinical investigations 551
Tri-Modal MALDI-MS Imaging on the Same Tissue Section: Deeper Molecular Insights of Disease 520
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy. 509
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 489
Lipidomic Typing of Colorectal Cancer Tissue Containing Tumour-Infiltrating Lymphocytes by MALDI Mass Spectrometry Imaging 464
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 453
PROTEOMIC CHARACTERIZATION OF HUMAN PLATELET LYSATE BY LABEL-FREE NLC-MS/MS: TOWARDS THE EFFECTORS OF ITS BENEFICIAL EFFECT IN REGENERATIVE MEDICINE 430
Spatially resolved inteRASomics: Can MS-imaging decipher RAS mutational status in thyroid cancer looking at RAS interacting proteins? 406
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 393
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 385
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 304
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 299
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 287
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 281
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 239
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 232
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 232
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 220
Biomarkers discovery through multivariate statistical methods to face clinical issues concerning thyroid tumour variants classification 182
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 179
THE MANAGEMENT OF HAEMOGLOBIN INTERFERENCE FOR THE MALDI-MSI ANALYSIS OF IN VIVO THYROID BIOPSIES 169
Does the Urinary Proteome Reflect ccRCC Stage and Grade Progression? 163
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 152
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 151
Putative salivary biomarkers useful to differentiate patients with fibromyalgia. 145
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 145
MS-Imaging inteRASomics: spatially resolved RAS interacting proteins enable to decipher RAS mutational status in thyroid cancer 131
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 124
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 124
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 119
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor as a Possible Indicator of Response to Therapy in Membranous Nephropathy 114
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 113
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 112
Correction to Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 108
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 101
Imagine beyond imaging: molecular snapshots of thyroid cancer 100
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 99
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 94
Spatial proteomics to overcome challenges in the diagnosis of follicular-patterned thyroid neoplasms entities: preliminary results 91
Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging in the Study of Gastric Cancer: A Mini Review 90
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 77
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 34
Sustainability of food packaging 32
Totale 18.353
Categoria #
all - tutte 21.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241.291 0 0 0 0 0 0 178 31 33 22 29 998
2024/202517.062 7.550 7.066 1.050 1.096 300 0 0 0 0 0 0 0
Totale 18.353